A pilot, multicenter, open-label, one-group study to explore the efficacy, tolerability and safety of 30 mg TV-5010 administered once weekly in subjects with relapsing-remitting multiple sclerosis.
A pilot, multicenter, open-label, one-group study to explore the efficacy, tolerability and safety of 30 mg TV-5010 administered once weekly in subjects with relapsing-remitting multiple sclerosis.
What it found
No result found
We found no results in the registry or in papers.
What was tested
Treatment tested
- Glatiramer acetate
Unknown
Loading reviews and guidelines…
Related trials
- TWINS
Phase 3 · Not yet recruiting
Still running
- AIOLOS
Recruiting
Still running
- Full Responders
Phase 4 · Stopped early
Stopped early
- A Study to Learn More About The Safety of Diroximel Fumar…
Running, not recruiting
Still running
- A Open-label Study to Assess Response to COVID-19 Vaccine…
Phase 4 · Stopped early
Stopped: safety
- A Study to Asses Efficacy, Safety and Tolerability of Mon…
Phase 3 · Completed
Met its main goal
History
Started
Aug 2012
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error